Yanping Mao

20PUBLICATIONS

76CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsRadiation therapyPredictive and prognostic markersCancer genetics

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (20)

Sort by Publication Date:

|Jul 01, 2026

Long-term outcomes of adjuvant metronomic capecitabine in locoregionally advanced nasopharyngeal carcinoma: a randomized, controlled, multicenter, phase 3 study.

|Jun 10, 2026

TQB2618 plus penpulimab, alone or in combination with chemotherapy, for recurrent or metastatic nasopharyngeal carcinoma: a multicentre, two-cohort, phase 2 trial.

|May 14, 2026

MYO1G Facilitates Caveolin-1-Mediated Endocytosis of the N-Terminal Fragments of Gasdermin E to Restrain Pyroptosis and Chemotherapy Efficacy.

|Mar 31, 2026

Medial retropharyngeal nodal region sparing radiotherapy in nasopharyngeal carcinoma: five year analysis of open label, non-inferiority, multicentre, randomised phase 3 trial.

Shun-Xin Wang, Ya-Lan Tao, Tian-Sheng Gao

|Mar 12, 2026

Risk-adaptive therapy guided by dynamic ctDNA in nasopharyngeal carcinoma.

Jiawei Lv, Dan-Xue Zheng, Jin-Hui Liang

|Feb 25, 2026

PD-1 inhibitors combined with induction chemotherapy followed by chemoradiotherapy in HPV-negative locally advanced head and neck squamous cell carcinoma: a real-world study.

Yi Yang, Shunxin Wang, Shuzhen Peng

Pageof 4

Frequent Collaborators

11 joint publications

Jun Ma

Ying Sun

Ling-Long Tang

Na Liu

Wen-Fei Li

Yu-Pei Chen

Ji-Bin Li